Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Ingwersen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Neuroscience Letters|April 7, 2019
Regulation of sirtuin expression in autoimmune neuroinflammation: Induction of SIRT1 in oligodendrocyte progenitor cellsTim Prozorovski, Jens Ingwersen, Denise Lukas, et al.
Annals of Clinical and Translational Neurology|August 22, 2018
Multifocal visual evoked potentials in chronic inflammatory demyelinating polyneuropathyJonas Graf, Lea Jansen, Jens Ingwersen, et al.
Annals of Clinical and Translational Neurology|February 3, 2015
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20bJens Ingwersen, Til Menge, Britta Wingerath, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 11, 2023
Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With OcrelizumabSteffen Pfeuffer, Leoni Rolfes, Jens Ingwersen, et al.
Glia|June 16, 2017
Iron-sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microgliaKlaudia Lepka, Katrin Volbracht, Eckhard Bill, et al.
Journal of Neurochemistry|February 24, 2018
Nimodipine confers clinical improvement in two models of experimental autoimmune encephalomyelitisJens Ingwersen, Lorenzo De Santi, Britta Wingerath, et al.
Frontiers in Immunology|August 21, 2023
Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controlsSaskia Räuber, Christopher Nelke, Christina B Schroeter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 15, 2021
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Journal of Neuroinflammation|November 6, 2019
Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitisAndrés Cruz-Herranz, Michael Dietrich, Alexander M Hilla, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 23, 2022
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Melanie Korsen, Niklas Huntemann, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Neuroscience Letters|April 7, 2019
Regulation of sirtuin expression in autoimmune neuroinflammation: Induction of SIRT1 in oligodendrocyte progenitor cellsTim Prozorovski, Jens Ingwersen, Denise Lukas, et al.
Annals of Clinical and Translational Neurology|August 22, 2018
Multifocal visual evoked potentials in chronic inflammatory demyelinating polyneuropathyJonas Graf, Lea Jansen, Jens Ingwersen, et al.
Annals of Clinical and Translational Neurology|February 3, 2015
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20bJens Ingwersen, Til Menge, Britta Wingerath, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 11, 2023
Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With OcrelizumabSteffen Pfeuffer, Leoni Rolfes, Jens Ingwersen, et al.
Glia|June 16, 2017
Iron-sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microgliaKlaudia Lepka, Katrin Volbracht, Eckhard Bill, et al.
Journal of Neurochemistry|February 24, 2018
Nimodipine confers clinical improvement in two models of experimental autoimmune encephalomyelitisJens Ingwersen, Lorenzo De Santi, Britta Wingerath, et al.
Frontiers in Immunology|August 21, 2023
Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controlsSaskia Räuber, Christopher Nelke, Christina B Schroeter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 15, 2021
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Journal of Neuroinflammation|November 6, 2019
Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitisAndrés Cruz-Herranz, Michael Dietrich, Alexander M Hilla, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 23, 2022
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Melanie Korsen, Niklas Huntemann, et al.
Pageof 3